Patents by Inventor Herve Dupont

Herve Dupont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR SCREENING MTP-INHIBITING COMPOUNDS
    Publication number: 20090220421
    Abstract: The present invention relates to a screening method for selecting active materials that inhibit microsomal triglyceride transfer protein (MTP) and to a screening kit using the said method.
    Type: Application
    Filed: April 12, 2006
    Publication date: September 3, 2009
    Inventors: Oliver Chevreuil, Herve Dupont, Daniel Duerrier
  • Butyric acid derivatives
    Patent number: 7491747
    Abstract: The present invention relates to a compound of the formula I: (Formula I) in which: A, B, R1, Z, n and R2 are as defined in claim 1. These compounds are useful in the treatment of dyslipidaemia, atherosclerosis and diabetes.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: February 17, 2009
    Assignee: Merck Patent GmbH
    Inventors: Roche Didier, Jean-Jacques Zeiller, Francis Contard, Valérie Guyard-Dangremont, Daniel Guerrier, Hervé Dupont, Jean-Jacques Berthelon
  • Promoter of the human fatp5 gene and uses
    Publication number: 20070105115
    Abstract: The invention relates to an isolated human nucleic acid, characterized in that it corresponds to the promoter of the human FATP5 protein, and to an isolated human nucleic acid coding for a protein, particularly for the human FATP5 protein, placed under the dependence of said promoter. The invention further relates to a vector comprising said nucleic acid, or to a host cell into which said nucleic acid or said vector has been introduced. Finally, the invention relates to the use of said nucleic acid, said vector or said host cell in a method of identifying a product capable of modulating the expression of a nucieotide sequence placed under the dependence of said promoter of the human FATP5 protein, and to said method of identification.
    Type: Application
    Filed: August 4, 2004
    Publication date: May 10, 2007
    Applicant: MERCK SANTE
    Inventors: Geneviève Martin, Guy Augert, Maryam Asfari, Herve Dupont, Daniel Ruggiero, Philippe Durbin
  • Butyric acid derivatives
    Publication number: 20050020651
    Abstract: The present invention relates to a compound of the formula I: (Formula I) in which: A, B, R1, Z, n and R2 are as defined in claim 1. These compounds are useful in the treatment of dyslipidaemia, atherosclerosis and diabetes.
    Type: Application
    Filed: July 3, 2002
    Publication date: January 27, 2005
    Inventors: Didier Roche, Jean-Jacques Zeiller, Francis Contard, Valerie Guyard-Dangremont, Daniel Guerrier, Herve Dupont, Jean-Jacques Berthelon
  • Process for simultaneous optical modulation transposition on several wavelengths
    Patent number: 5555121
    Abstract: A process for a simultaneous optical modulation transposition on several wavelengths. Use is made of a semiconductor laser able to freely oscillate on several longitudinal modes, the semiconductor laser being able to lock on a wavelength of an incident optical beam. The modulation is transposed on the modes which are not at the wavelength of the incident optical beam. Such a process may find particular application in optical telecommunication systems.
    Type: Grant
    Filed: September 15, 1995
    Date of Patent: September 10, 1996
    Assignee: France Telecom Establissment autonome de droit public
    Inventors: Herve Dupont, Mouhamad Chawki, Georges Claveau
  • Process for the transposition of an optical modulation of one wavelength to another adjustable wavelength
    Patent number: 5539760
    Abstract: A process for the transposition of a modulation of an adjustable wavelength. A semiconductor amplifier is relooped through a feedback loop including a filter set to a first wavelength. An incident beam set at a second wavelength which is amplitude modulated is injected into the semiconductor amplifier laser. The incident beam is either extinguished or allows self-oscillation to be established in the loop. Thus, the modulation is transposed from the second wavelength to the first wavelength.
    Type: Grant
    Filed: September 2, 1994
    Date of Patent: July 23, 1996
    Assignee: France Telecom Etablissement autonome de droit public
    Inventors: Herve Dupont, Rene Auffret, Andre Tromeur